Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis.
about
RyR2 and calpain-10 delineate a novel apoptosis pathway in pancreatic isletsRegulation of glucose homeostasis by GLP-1Epac: A new cAMP-binding protein in support of glucagon-like peptide-1 receptor-mediated signal transduction in the pancreatic beta-cellSteering Endogenous Butyrate Production in the Intestinal Tract of Broilers as a Tool to Improve Gut HealthBiological effects of bariatric surgery on obesity-related comorbiditiesDesign and synthesis of 4-(2,4,5-trifluorophenyl)butane-1,3-diamines as dipeptidyl peptidase IV inhibitorsSynergy of glucose and growth hormone signalling in islet cells through ICA512 and STAT5A novel glucagon-related peptide (GCRP) and its receptor GCRPR account for coevolution of their family members in vertebratesGlucose-dependent insulinotropic polypeptide-mediated up-regulation of beta-cell antiapoptotic Bcl-2 gene expression is coordinated by cyclic AMP (cAMP) response element binding protein (CREB) and cAMP-responsive CREB coactivator 2Maternal deprivation alters epithelial secretory cell lineages in rat duodenum: role of CRF-related peptidesPharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus.The entero-insular axis: implications for human metabolism.Diabetes resolution and hyperinsulinaemia after metabolic Roux-en-Y gastric bypass.Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure.Sensory nerves contribute to insulin secretion by glucagon-like peptide-1 in mice.Transcriptional response of pancreatic beta cells to metabolic stimulation: large scale identification of immediate-early and secondary response genes.Post-Gastric Bypass Hyperinsulinemic Hypoglycemia: Fructose is a Carbohydrate Which Can Be Safely Consumed.Myricetin: a potent approach for the treatment of type 2 diabetes as a natural class B GPCR agonist.Gene expression profiles of colonic mucosa in healthy young adult and senior dogs.Recent advances in the regulation of cholangiocyte proliferation and function during extrahepatic cholestasisThe incretin system and cardiometabolic diseaseLoss of enteroendocrine cells in mice alters lipid absorption and glucose homeostasis and impairs postnatal survival.Gut microbiota, probiotics and diabetes.Activation of GPR40 attenuates chronic inflammation induced impact on pancreatic β-cells health and function.Regulators of Cholangiocyte Proliferation.Effects of Dipeptidyl Peptidase-4 Inhibition with MK-0431 on Syngeneic Mouse Islet TransplantationPioglitazone and alogliptin combination therapy in type 2 diabetes: a pathophysiologically sound treatment.Transcriptional regulation of α-cell differentiation.Reversal of hyperglycemia in diabetic rats by portal vein transplantation of islet-like cells generated from bone marrow mesenchymal stem cellsA Novel Long-Acting Glucagon-Like Peptide-1 Agonist with Improved Efficacy in Insulin Secretion and β-Cell Growth.Hepatic and glucagon-like peptide-1-mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors.Stimulation of glucagon-like peptide-1 receptor through exendin-4 preserves myocardial performance and prevents cardiac remodeling in infarcted myocardium.Incorporating incretin-based therapies into clinical practice: differences between glucagon-like Peptide 1 receptor agonists and dipeptidyl peptidase 4 inhibitors.Glucagon-like peptide-1 and-2 levels in children with diabetic ketoacidosisEpac2-dependent rap1 activation and the control of islet insulin secretion by glucagon-like peptide-1.Genome-wide screening of genes regulated by DNA methylation in colon cancer development.Proglucagon-derived peptides: mechanisms of action and therapeutic potential.The efficacy and safety of saxagliptin when added to metformin therapy in patients with inadequately controlled type 2 diabetes with metformin aloneChronic treatment with the GLP1 analogue liraglutide increases cell proliferation and differentiation into neurons in an AD mouse model.GLP-1 could improve the similarity of IPCs and pancreatic beta cells in cellular ultrastructure and function.
P2860
Q24320352-D17F1011-063F-4829-82EE-C78BCA8D35DCQ24563430-75FABFFB-FD1B-4B2D-85C7-121156364891Q24619138-36B2CE43-B56C-465A-8989-CEF102F63E39Q26770503-9CB90FB6-CD50-4B4D-A827-0E0F2846F9A8Q26860509-A7EDCC24-8578-4F9D-AB21-34DF9AD61F04Q27684616-5B4199E4-2785-4012-B3C4-74FBCFC57751Q28117194-E3ABE14A-654B-4322-8081-A2D87741D5E0Q28533808-7E932410-8836-4A1F-BF40-45A5B3F97968Q28572231-BCD13100-40F6-4912-88AB-B7FA015C756CQ28572873-2300C485-3FD1-45BE-8602-CABD72339E61Q30249371-18B2B611-61D1-41F3-A625-D43591DA8E72Q30365939-8505F293-E82D-47FD-89DF-ECC53F0A51B4Q30394286-54B0D805-7436-46A4-9118-3EB8486F5AFAQ30478488-3341814F-3EFF-45B2-BE9C-D1046BF7589CQ33196495-BDABE6F5-A211-4850-9EE8-55D73C2DCD9AQ33288625-FA2D3CC6-A08A-4B67-98CA-D7DCD68541C7Q33570292-C518DE52-62B3-4955-954E-730644C0F62DQ33697296-1A8031FB-2394-4040-BD28-05C1C18567AFQ33705103-7F42179E-7924-4C9E-9A6E-E166B9871E86Q33718790-B0EEB798-3FDE-4263-9757-2A144AA10CEBQ33776092-C0AFADDD-DFC2-4742-8685-EA44B37F1A33Q33815664-1825598B-DC18-4EF3-977A-53F01ACDFE13Q33831849-B5BE3CA0-AD5E-4115-8F50-A78A0B47A8BCQ33850372-ECBCC052-B4D4-419F-A0F2-CC73065B4601Q33863341-AE1B4EA1-3DAB-4E41-9507-99ECCB7C41BBQ34069011-286B2539-38AC-4EE7-89F6-5B57F646CDF6Q34139048-E0A0879F-FD7F-4636-A7AB-95D1B76E7EB6Q34206599-7E83C09F-933A-4C1C-88B5-5FADB5F81E8AQ34233041-F08C35EE-E332-4538-946B-137ED6E763B1Q34318785-AAE6E6BD-7FF7-4D41-BFCF-5B44378D9592Q34328200-F6AB07EB-9AC5-4838-9130-A2C5424E08E1Q34355984-E3854A4D-871B-4002-BB8F-FE2B15D9B02EQ34374336-C6F53D92-F28A-48A5-A1E8-ACB236F94AA4Q34423035-C522D8C8-098A-4081-8870-B424DBF34819Q34436421-4686F035-60C5-48CB-A2CC-CB2D9E7D90E8Q34437619-FA37CA68-6CEC-47C1-A76D-B9490B1861E1Q34452524-02B08F69-DCD3-4EFF-9908-D14C60CADA37Q34608300-F0971E8E-6338-4161-A3D6-1A91E1230134Q34639384-88C4C047-E2C6-4617-AA04-16ADA88156BAQ34647309-E130B1CE-F3E5-46E2-94CD-DF803018BE90
P2860
Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis.
@ast
Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis.
@en
Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis.
@nl
type
label
Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis.
@ast
Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis.
@en
Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis.
@nl
prefLabel
Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis.
@ast
Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis.
@en
Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis.
@nl
P356
P1476
Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis.
@en
P304
P356
10.1210/ME.2002-0306
P577
2003-02-01T00:00:00Z